A full-length DNA clone of a virulent strain of rinderpest virus was constructed with the gene for the enhanced green fluorescent protein (eGFP) inserted as a separate transcription unit between the P and M genes. Rescue of the virus from the modified clone using reverse genetics generated a virus that grew to the same levels as the virus rescued from the unmodified DNA clone in cell culture. The recombinant virus expressed eGFP to a high level and was used to follow virus replication in real-time using live-cell imaging. Cattle infected with both the recombinant wild-type virus and the recombinant eGFP expressing virus developed clinical disease similar to that of the wild-type natural virus isolate. Detection of virus in circulating peripheral blood leukocytes was equivalent to that of the animals infected with the wild-type virus. The high level of expression of soluble eGFP by this virus allowed us to detect viral replication in infected animals by confocal microscopy. Imaging vibrating microtome sections by confocal microscopy provided good preservation of tissue and cellular architecture as well as revealing the sites of replication of the virus in different tissues of infected animals.
INTRODUCTION
Following a coordinated long-term vaccination programme and serosurveillance effort across much of Africa and Asia, Rinderpest virus (RPV) is on the verge of global extinction. Despite this, RPV remains an excellent model for studying morbillivirus molecular biology and pathogenesis. RPV is a member of the order Mononegavirales, family Paramyxoviridae, subfamily Paramyxovirinae, genus Morbillivirus, a group of RNA viruses that includes a number of highly important pathogens of both humans and animals including human measles virus (MeV), peste des petits ruminants virus (PPRV), the cause of a devastating plague of small ruminants and canine distemper virus (CDV) . As such, these viruses contain single-stranded, non-segmented, negativesense (39-59) RNA genomes capable of producing up to eight proteins: the nucleocapsid protein (N), phosphoprotein (P), matrix protein (M), fusion protein (F), haemagglutinin protein (H) and polymerase protein (L) as well as two non-structural accessory proteins, C and V, generated by alternative RNA editing mechanisms from the P gene ORF . A transcriptional gradient exists during viral transcription such that the production of these proteins is skewed. The 39 proximal protein (N) is produced in abundance, whilst those distal to the 39 end of the genome are produced to lower levels the further from the 39 end of the genome that they are located .
The ability to generate full-length cDNA copies of negativestrand virus genomes and manipulate them to generate live virus by using reverse genetic techniques has vastly improved our knowledge of the members of the order Mononegavirales. In this way, the molecular features affecting their growth and replication cycle, including basic sequence requirements, mechanisms of transcription and replication, interaction with cellular components as well as the interaction between viral proteins have been extensively studied Baron et al., 2005; Brown et al., 2005; Duprex et al., 1999 Duprex et al., , 2000 Duprex et al., , 2002 Panda et al., 2004; Silin et al., 2007; Wertz et al., 1998; An important question when considering the manipulation of negative-strand virus genomes for both vaccine development and virulence studies is that of coding capacity. Previous studies have looked at the potential of negative-strand viruses to tolerate novel transcription units engineered into their genomes and have evaluated how the extra non-viral genetic material affects the viral growth kinetics (Das et al., 2006; Duprex et al., 2000 Duprex et al., , 2002 Silin et al., 2007; Wertz et al., 2002) . Studies with morbilliviruses have looked at the insertion of reporter genes at various different positions within the genome. CDV expressing eGFP as a separate transcription unit positioned between the nucleocapsid gene and the genome promoter was successfully rescued and shown to be replication competent, whilst maintaining the ability to persist in vitro (Plattet et al., 2004) . Recently, virulent and attenuated measles viruses expressing GFP have been used to compare infection in vivo via different routes using a macaque model (de Vries et al., 2010) .
For RPV, previous studies have involved both pathogenesis and vaccine development. Insertion of eGFP directly into the second hinge region of the RPV L protein was shown to generate a virus that could be visualized in vitro through the positioning and functionality of eGFP present within the L protein. This virus retained the growth kinetics of the wild-type parent virus in vitro, but was drastically attenuated in vivo when inoculated into the natural host for RPV, cattle (Brown et al. 2005) . A further study carried out with CDV gave similar results when assessing pathogenicity of the recombinant virus in ferrets (Silin et al., 2007) . Studies with the RPV vaccine strain initially centred around tagging the vaccine by positioning a reporter gene between the P and M genes to attempt to generate a positively marked vaccine to which vaccinated animals would generate anti-eGFP antibodies and thus allow differentiation of naturally infected and vaccinated animals in the field. Unfortunately not all animals vaccinated with this recombinant vaccine generated strong antibody responses to the reporter gene as planned (Walsh et al., 2000a, b) . An RPV marked vaccine was, however, successfully generated through the swapping of the N gene of PPRV in place of that of RPV in the RPV vaccine. The resulting virus RP-PPRN grew well in tissue culture and conferred protective immunity to vaccinated animals, which could be serologically distinguished from those naturally infected with RPV by the presence of anti-PPRV N-specific antibodies and a PPRV N-specific ELISA test (Parida et al., 2007) .
Here, we describe the generation of a highly virulent form of RPV, the Kabete 'O' (KO) strain of RPV expressing eGFP as a novel transcription cassette positioned between the P and M proteins and describe its growth in vitro and in vivo. Furthermore, we report visualization of this recombinant virus using live-cell imaging and demonstrate the ability to visualize eGFP containing cells in tissue sections taken from infected cattle.
RESULTS

Rescue and growth of recombinant KO with an insertion of eGFP (rKOIns-eGFP) in vitro
Rescue of the rKOIns-eGFP virus was carried out using a full-length clone, which contained the full-length antigenomic sequence under the transcriptional control of the T7 promoter as described for the RBOK strain (Baron & Barrett, 1997) . Rescue was achieved using both B95a and Vero cells expressing the morbillivirus receptor molecule signal lymphocyte activation molecule (Vero-SLAM). Recombinant virus, rKOIns-eGFP, was recovered between 3 and 5 days post-transfection in several independent rescue experiments from both cell lines. Virus-induced CPE was assessed for expression of eGFP by confocal microscopy on B95a cells (Fig. 2a, b) . The eGFP was expressed to high levels in the infected cells. Nonfluorescent syncytia were not observed at any point after passage, indicating that eGFP expression was stable. Rescued virus was serially passaged 10 times in each cell line to ensure the stability of the inserted transcription cassette. Rescued virus was passaged three times in both B95a and Vero-SLAM cells and virus was quantified by titration. The growth characteristics of the B95a-rescued recombinant virus was assessed in this cell line in comparison to wild-type virus rescued in B95a cells. Infected cells were titrated at 0, 12, 24, 36, 48, 60, 72, 84 and 96 h post-infection (p.i.) using a TCID 50 assay. The overall replication rate of the two viruses in B95a cells was similar and titres of between 10 5 and 10 6 TCID 50 ml
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were achieved by 96 h p.i. (Fig. 3a) . Growth analysis was also carried out in Vero-SLAM cells and again, the two viruses were seen to grow to comparable titres (Fig. 3b ).
Live-cell imaging of rKOIns-eGFP in B95a and Vero-SLAM cells 
Pathogenicity of rKOIns-eGFP in cattle
Previously, we showed that expression of eGFP from within the polymerase protein has little effect on the rate of replication in vitro but attenuates the virus in vivo (Brown et al., 2005) . Having found little difference in replication rate between rKOIns-eGFP and rRPVKO in vitro we decided to examine whether or not the introduction of eGFP as a separate transcription unit into the genome of KO altered pathogenicity in vivo.
Four out-bred Friesian Holstein (6 month old) cattle were used in the pathogenicity experiments. Animals were housed separately in two groups. Two animals, VS49 and VS50, were infected with 10 4 TCID 50 rRPVKO, while in another isolation box, animals VS51 and VS52 were infected with 10 4 TCID 50 rKOIns-eGFP. Animals were monitored for typical signs of rinderpest infection including rectal temperatures, leukopenia and clinical signs such as ocular and nasal discharge and mouth lesions.
Prior to infection, the rectal temperatures of all four cattle fluctuated around 38 u C. To try and establish with greater accuracy exactly when the rKOIns-eGFP animals became pyrexic, rectal temperatures were taken at 6 h intervals until pyrexia was seen, rather than at the standard 24 h intervals (6 hourly interval data not shown). VS49 and VS50 developed temperatures of greater than 39.5 u C at 48 h p.i. VS51 and VS52 became pyrexic by 60 h p.i., exhibiting temperatures of 41 and 39.1 u C, respectively. All animals maintained high temperatures until they had to be euthanized in accordance with defined humane end-points for this level of experimentation (Fig. 4a ).
Leukopenia is another clinical feature associated with morbillivirus infections and white cell counts (WBC) for the cattle were assessed at 24 h time points pre-and postinfection. Pre-infection WBC levels varied between 3000 and 5000 cells mm 23 for the four animals. Severe leukopenia is typical following infection with rinderpest and by day 4 p.i. all animals had WBC that were less than 50 % of the pre-infection levels and these levels continued to drop until the animals were euthanized (Fig. 4b) . Detection of virus in isolated peripheral blood leukocytes (PBL) was carried out using standard RT-PCR (Table 1) . Generally, RT-PCR techniques detected viral nucleic acid in PBL by day 2 p.i. although for VS51 RPV-specific primers gave a positive product on day 1 p.i. (Table 1) . Where assessed, PBL put onto Vero-SLAM cells for isolation were positive by day 7 but not before. This is consistent with previous studies that have shown that isolation from tissue culture is far less sensitive than PCR techniques . Positive isolation was detected by the formation of syncytia. Samples found to be positive from rRPVKO-infected animals were negative for GFP fluorescence, whilst virus isolated in cell culture from animals infected with rKOIns-eGFP showed GFP expression by confocal microscopy.
Post-mortem findings
The two animals infected with rRPVKO developed classical pathological signs of infection normally seen with this strain of the virus. Both of the wild-type-infected animals (VS49 and VS50) were euthanized on day 6 p.i., whilst the two animals infected with rKOIns-eGFP were euthanized on days 7 (VS52) and 8 (VS51), respectively. The two animals infected with rKOIns-eGFP displayed typical postmortem pathology, including mild erosion of the oesophageal mucosa, swollen lymph nodes, enlarged spleen, emphysema, eroded congested mucosa and haemorrhages on colonic ridges of the descending colon that gave the classic appearance of 'zebra stripes' associated with RPV infection (Anderson et al., 1996; Wohlsein et al., 1995) . Clinical signs at post-mortem were less severe in animal VS51 than seen in either the wild-type-infected animals (VS49 and VS50) or VS52.
Distribution of virus in post-mortem tissues
Post-mortem tissues from the two animals infected with rKOIns-eGFP (VS51 and VS52) were examined for the Virulent RPV expressing eGFP presence or absence of eGFP to determine if we could observe differences in tissue distribution at this critical time point, where often animals either succumb to infection or clear the virus and start to convalesce. The presence or absence of eGFP in each of the tissues examined is shown in Table 2 . Analysis of post-mortem tissues from animal VS52, euthanized 7 days p.i., revealed extensive eGFP expression. Almost all tissues examined were clearly positive for eGFP expression. In several tissue types, including the gall bladder, bronchial lymph node, left and right prescapular lymph nodes, mesenteric lymph node and mandibular lymph nodes, eGFP was mainly seen at junctions between blood or lymph vessels and tissues, the level of virus infiltration into tissue being seen as either individual cells near vessels being infected or large multinucleate syncytia being present. Tissues examined from the gastrointestinal tract were also strongly positive for eGFP expression with extensive expression seen in the ascending colon where high numbers of positive cells were visible both near blood vessels and throughout the remaining tissue. The goblet/crypt cells of the descending colon were positive for eGFP expression as were the Bruhners glands in the duodenum (Fig. 5a ). The epithelial layers of the eyelid and tongue were also strongly positive as were the trachea and the tonsils. Within the trachea, eGFP expression was evident throughout the section being present in the respiratory epithelium, the mucosae and the submucosa that contains the tracheal glands (Fig. 5b) . Animal VS51 was euthanized on day 8 p.i. In contrast to VS52, this animal was negative for the majority of tissues examined although virus was still evident in the lip, eyelid and trachea where singly infected cells were seen. Other tissues positive for eGFP include the descending colon, the abomasum and the duodenum where singly infected-positive cells were seen within the epithelial layer (Table 2) . These findings correlate with previous immunohistochemical analyses of virus distribution in animals showing clinical disease following infection with wild-type strains of RPV (Wohlsein et al., 1995) .
RT-PCR analysis of tissues taken post-mortem for each of the animals is detailed in Table 3 . Here, both eGFP-and RPV-specific PCRs were performed. For VS49 and VS50, RPV was detected in all tissue samples, whilst PCR undertaken with eGFP-specific primers were all negative. For animals VS51 and VS52, detection of RPV was consistent with that of eGFP except for in the mesenteric lymph node and mediastinal lymph node for VS51 and in the mediastinal lymph node for VS52 where RPV was detected, whilst eGFP was not detected by standard PCR.
DISCUSSION
A full-length DNA clone of a pathogenic isolate of RPV, expressing eGFP as a reporter gene from a separate transcription unit, was constructed. Previously, we showed that the genome of the virulent RPV KO strain could tolerate the insertion of eGFP into the second hinge region of its polymerase (L) gene and that viable virus expressing eGFP in-frame within the L protein could be rescued and grown to titres comparable with that of the parent virus (Brown et al., 2005) . However, this recombinant virus was attenuated in cattle, perhaps because the polymerase protein was debilitated by the extra sequence insertion. In this study, we examined whether or not insertion of eGFP as a separate transcription unit also attenuated the virus.
The eGFP transcription cassette was inserted between the P and M genes to avoid altering the balance of nucleoprotein and phosphoprotein required for transcription and replication (Walsh et al., 2000a) . It was hoped that inclusion of the extra gene would not alter the pathogenic potential of the virus for its natural host, cattle, and allow virus replication to be followed in organs and tissues. The recombinant full-length clone was used to rescue and passage virus in two different cell lines and its growth in vitro was compared to that of the virulent recombinant KO strain of the virus. Growth curves showed growth of the recombinant to be comparable to that of the unmodified virus and similar end-point titres were reached in infected cells in either cell line. Subsequent infection of cattle with these viruses showed that inclusion of the reporter gene did not significantly affect pathogenicity. Animals infected with both the rRPVKO and rKOIns-eGFP clones developed classical signs of rinderpest infection and all had to be euthanized according to the severity end-points pre-defined for this type of experimentation. Whilst there was a slight delay in the appearance of clinical disease in the animals infected with the eGFP expressing recombinant, the time points at which cattle had to be euthanized fell within an observed range following infection with the KO strain of RPV . Previous studies with both the wild-type KO virus and rRPVKO have shown that animal-to-animal variation can lead to the development of severe clinical disease between 6 and 9 days p.i. with some animals developing disease but not succumbing to infection. Experimental studies with other strains of RPV have also shown that whilst morbidity rates are often very high, mortality rates can vary between 30 and 90 % depending on the infecting strain (Taylor, 1986) . It is accepted that correlates of pathogenicity are poorly understood for the morbilliviruses with both immune status of the host and genetic background of the infecting virus playing roles in the outcome of infection (Taylor et al., 1965; Taylor, 1986; Wamwayi et al., 1995) . Using this approach with the virulent virus showed that inclusion of a heterologous gene between the P and M genes is tolerated and that the pathogenic potential of the resultant virus is comparable to that of the wild-type parent. The ability of this virus to express eGFP to high levels meant that eGFP expression could be observed in organs at post-mortem and could be used to trace the virus in tissue samples prepared for confocal microscopy.
Cattle infected with the wild-type KO strain of the virus generally develop all the characteristic signs of rinderpest infection (pyrexia, leukopenia, mucosal lesions and diarrhoea) by day 6 or 7 p.i. and have to be euthanized on ethical grounds between days 6 and 9. Using eGFP expression as a marker of virus replication, we studied the various tissue samples taken from animals euthanized on days 7 and 8 p.i. The animal (VS52) euthanized on day 7 was positive for eGFP expression in nearly all of the tissues examined while, in contrast, the animal (VS51) euthanized on day 8 showed eGFP in only a few of the tissues examined. This difference between the two animals showing similar clinical disease may be due to animal-toanimal variation but equally, VS51 may represent an animal that was effectively clearing the virus and if left may well have gone on to convalesce. Differences seen in the detection of RPV over that of eGFP by RT-PCR may be a consequence of the transcriptional gradient seen with these viruses where the 39 proximal gene mRNA is produced in abundance over downstream genes. Differences seen between eGFP detection by PCR compared with confocal microscopy are probably due to the fact that PCR was carried out following homogenization of a small block (~30 mg) of tissue, whilst confocal detection of eGFP relied on scanning processed slices through the sample of interest. In such cases, PCR analysis will always be more sensitive. Historic experiments with greater numbers of animals have shown that the infection is not 100 % fatal and that some animals that develop severe disease may still clear the virus and go on to convalesce (Taylor et al., 1965; Taylor, 1986; Wamwayi et al., 1995) . Studies with greater numbers of animals would be needed to determine if the rate of virus clearance is related to convalescence in cattle infected with this virus. Furthermore, to assess virus distribution over time, experimentation would ideally be carried out by euthanizing groups of animals at different stages of clinical disease following infection and evaluating distribution using both molecular and histopathological techniques. Studies on foot-and-mouth disease virus (FMDV) infections of large ruminants have shown that virus clearance can be rapid, even within 1 day, and whilst mechanisms behind clearance remain unclear it is speculated that the host immune response contributes significantly (Paul Monaghan, personal communication). Cellmediated immunity through T cells is known to play an important role in virus clearance and recovery in the case of rinderpest and other morbilliviruses (Cosby et al., 2006; Sinnathamby et al., 2004) and this could be the reason for the rapid clearance of virus between days 7 and 8.
This study shows that infection with pathogenic viruses can be followed with relative ease in animal tissues by means of the eGFP reporter gene. Distribution of eGFP in infected tissues from rKOIns-eGFP-infected animals did not appear to differ from that seen following infection with rRPVKO and correlated with historical observations regarding RPV tissue distribution. Whilst not directly compared to conventional histopathological techniques in a quantitative manner here, the detection of eGFP in tissues is clearly a useful molecular tool with which to study viral distribution. This work suggests that the detection of eGFP rather than virus antigen using conventional techniques may be useful to overcome applications where antibody availability, sensitivity or cross-reactivity are problematic. It also appears that this approach could be applied to the study of other negative-strand viruses without significantly affecting pathogenesis. Furthermore, this virus can be used to investigate the sites of virus replication in cell cultures and the means whereby the virus spreads from cell to cell when syncytia form. Other key questions relating to virus entry and exit mechanisms could be addressed by using this system.
This approach may also be of significance for the future study of the pathogenesis of the closely related and economically important PPRV. Detection of reporter gene expression would also be useful for the investigation of the effects of different drugs on the growth of the virus in tissue culture, especially using live-cell imaging, with a view to developing therapeutic reagents to control morbillivirus infections in the host animal. As yet there is no effective means of treating animals following infection with morbilliviruses.
METHODS
Cell culture. B95a cells (Kobune et al., 1991) were grown at 37 uC/ 5 % CO 2 in RPMI 1640 medium (Invitrogen) containing 5 % (v/v) FBS and antibiotics. Vero cells expressing the canine form of the morbillivirus receptor SLAM (von Messling et al., 2003) were grown at 37 uC/5 % CO 2 in Dulbecco's modified Eagle's medium containing 5 % (v/v) FBS and antibiotics.
Construction of a DNA clone of RPV with an eGFP gene insertion. The RPV used in the study was the virulent KO strain. Total cell RNA was purified from B95a cells infected with the virus by using Trizol (Invitrogen) and cDNA was prepared as described previously (Baron & Barrett, 1997) . All PCR used KOD polymerase (Novagen) according to the manufacturer's instructions. Other DNA manipulations were performed using standard techniques. Plasmids were cloned in E. coli strains DH5a or JM109 and preparation and purification of plasmids was performed using caesium chloride gradients (Baron & Barrett, 1997) .
The construction of the full-length DNA clone of the KO strain of RPV was described previously . The generation of the pathogenic virus expressing eGFP (rKOIns-eGFP) was achieved by manipulation of the full-length DNA clone to insert a separate transcription unit with authentic gene start and stop motifs between the P and M genes (Baron et al., 1999) . A fragment spanning from genome position 2138 within the P ORF to position 6118 in the F ORF was amplified from the full-length DNA clone using KOD polymerase (Novagen) and the resulting 3980 bp PCR product was blunt cloned into the Zero Blunt TOPO PCR cloning vector (Invitrogen) and stock generated by transformation into TOPO One Shot chemically competent cells (Invitrogen). This intermediary vector was then prepared for the addition of the eGFP ORF by digestion with SphI. The eGFP ORF was amplified from RPVIns-GFP (Walsh et al., 2000a) using mutagenic primers that added SphI sites at either end of the ORF. The resulting PCR product was digested with SphI and ligated into the SphI linearized intermediary vector. An SbfI site at position 3354, 23 nt upstream of the P gene end sequence and a SwaI site at position 4456, 11 nt downstream of the M protein ORF start site and 401 bases upstream of the intergenic trinucleotide were then used to cut the required fragment out of the intermediary vector and insert it back into the full-length KO clone prepared with the SbfI and SwaI restriction enzymes. Fig. 1 shows a schematic diagram of the full-length rKOIns-eGFP genome plasmid including the positions of restriction enzyme sites used in this study.
Virus rescue from full-length genomic cDNA. Virus from fulllength genomic cDNA was rescued and passaged in two different cell lines using techniques specific for each cell line. For Vero-SLAM cells, the cells were seeded in six-well plates (2610 5 per well) the day before rescue. The following day the cells were infected with recombinant fowlpox expressing the T7 RNA polymerase (FP-T7) at an m.o.i. of approximately 0.5 (Britton et al., 1996) and transfected with helper plasmids derived from the vaccine strain of rinderpest encoding the N, P and L proteins plus the plasmid containing the full-length virus genome cDNA as described previously (Das et al., 2000) . Between 3 and 5 days later, upon the appearance of cytopathic effect the cells were frozen to 280 uC. The cells were thawed to release virions, and the extract clarified [2500 r.p.m. (IEC Centra GP8R centrifuge with a CAT218A rotor), 5 min]. Fresh Vero-SLAM cells were infected with 1 ml of supernatant and this procedure was repeated twice more to obtain passage level three virus stocks.
B95a cells were also used for virus rescues. These cells were seeded at approximately 2610 6 cells per well in a six-well plate 2 days before transfection. Cells were infected with recombinant vaccinia virus expressing the T7 RNA polymerase (vTF7-3) (Fuerst et al., 1986) at an m.o.i. of~0.2 for 1 h before transfecting with the full-length genome and helper plasmids as described above. Cells were observed daily for cytopathic effect and rescue events were taken through three freezethaw cycles described above. Clarified supernatants were stored at 280 uC to act as stocks at each passage level.
Virus growth curves. B95a cells or Vero-SLAM cells were cultured to 70 % confluence in six-well plates. Cells were infected at an m.o.i. 0.01 for 1 h at 37 uC, after which time the virus inoculum was removed and replaced with fresh medium. Infected cells were incubated at 37 uC and infections were terminated at regular intervals, up to 96 h p.i., by freezing to 280 uC. Supernatants were clarified by centrifugation [2500 r.p.m. (IEC Centra GP8R centrifuge with a CAT218A rotor), 5 min, 4 uC] and virus titres were determined by 10-fold serial dilution of sample on either Vero-SLAM or B95a cells. For each sample, 12 replicates were performed and titre calculated according to methods described previously (Reed & Muench, 1938) . Live-cell imaging was carried out by plating cells out at an appropriate density (1610 6 for B95a cells and 1.5610 5 for Vero-SLAM cells) on Iwaki Glass base 35 mm dishes (Asahi Techno Glass Corporation). After overnight incubation, cells were infected at an m.o.i. of~0.01 and monitored until eGFP expression was detected. Once eGFP was visualized, the medium was changed for L-15 Leibovitz air-buffered medium (Sigma) and the infection was followed using Leica Confocal Software (Leica Microsystems). Images were taken at 640 magnification with 5126512 resolution.
Experimental cattle infection. All animal experimentation was carried out in accordance with national legislation governing the use of animals for research, and with the approval of the local ethical review body in the Specific Animal Pathogens Order category 4 animal isolation units at the Institute for Animal Health, Pirbright. All procedures relating to the experiment were carried out by skilled staff under an approved Home Office license for animal experimentation. Animals were housed in this facility for at least 2 weeks prior to infection and were thoroughly checked to ensure they were in good health. Animals were fed on commercial pelleted food concentrates and hay. Six-month-old out-bred Friesian Holstein bullock calves were used in all animal experimentation. Each animal was infected with 1 ml (10 4 TCID 50 ) units of virus subcutaneously. Rectal temperatures were monitored daily, and blood was sampled before infection and at intervals thereafter. For the first 3 days p.i., blood was taken at 6 h intervals, in accordance with the limits of the project license, and once daily thereafter for 14 days or until humane end points for the experimentation were reached. The WBC was determined on heparinized blood by lysing the erythrocytes in 1 % (v/v) acetic acid and counting surviving cells using an Improved Neuerbauer haemocytometer. PBL were purified from approximately 30 ml heparinized blood as described previously (Ohishi et al., 1999) . For virus isolation, approximately 500 ml PBL were cultured with B95a cells in a 25 cm 2 flask to detect cell-associated virus in the blood. Cultures were considered positive if virus was detected within 1 week, without further passage of the cells. Where syncytia developed, expression of eGFP was assessed using confocal microscopy. For viral RNA detection by RT-PCR, 500 ml PBL was lysed in Trizol for RNA purification. The presence of viral RNA in PBL was determined by standard RT-PCR using both universal morbillivirus N gene-specific primers (Forsyth & Barrett, 1995) and eGFP-specific primers in a standard RT-PCR (Invitrogen).
Extraction of RNA from post-mortem tissues. Briefly, RNA was purified following homogenization of tissues (~30 mg) taken at postmortem using the FastPrep-24 tissue homogenizer (MP Biomedicals) using Tri-Reagent (Invitrogen) as per manufacturer's instructions. Diagnostic RT-PCR using universal N gene primers and eGFPspecific primers to detect viral RNA in samples was performed essentially as described previously (Forsyth & Barrett, 1995) , except that Hot-Start KOD polymerase was used. PCR products were analysed by agarose gel electrophoresis as described previously .
Preparation of tissues for histology. Tissues were fixed in 4 % paraformaldehyde for 2 h and transferred to PBS at 4 uC. Tissue sections were cut at 70 mm using a Leica VT1000S (Leica Microsystems) vibrating microtome. Sections were either viewed directly to detect eGFP fluorescence or, if antibody labelling was also required to be carried out, they were permeabilized in 0.1 % Triton X-100 (Sigma) for 1 h at room temperature and blocked overnight in blocking buffer (PBS supplemented with 0.05 % sodium azide, 0.5 % BSA; PBS/BSA). Sections were incubated with primary antibody diluted 1 : 1000 in PBS/BSA for 90 min at 37 uC and then washed in PBS. Primary antibodies were detected with species-specific Alexa Fluor 568 conjugate (Invitrogen) diluted 1 : 200 in PBS/BSA for 90 min at 37 uC. The sections were washed in PBS then nuclear DNA was labelled with DAPI diluted 1 : 5000 in distilled water for 20 min. After washing in ultrapure water the sections were mounted onto glass slides using Vectashield Mounting Medium.
